Correction: HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3.
作者信息
Sun Jianrui, Wang Lin
机构信息
Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Zhengzhou, 450052, Henan, China.
Information Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
出版信息
BMC Cancer. 2022 Apr 28;22(1):467. doi: 10.1186/s12885-022-09579-0.
Abstract
摘要
相似文献
1
Correction: HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3.更正：HOXA-AS2通过抑制miR-2116-3p从而上调SERPINA3来增强胶质母细胞瘤细胞的恶性程度。
BMC Cancer. 2022 Apr 28;22(1):467. doi: 10.1186/s12885-022-09579-0.
2
HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3.HOXA-AS2 通过抑制 miR-2116-3p 从而上调 SERPINA3 来增强 GBM 细胞的恶性程度。
BMC Cancer. 2022 Apr 6;22(1):366. doi: 10.1186/s12885-022-09462-y.
3
Knockdown of lncRNA HOXA-AS2 Inhibits Viability, Migration and Invasion of Osteosarcoma Cells by miR-124-3p/E2F3.lncRNA HOXA-AS2的敲低通过miR-124-3p/E2F3抑制骨肉瘤细胞的活力、迁移和侵袭。
Onco Targets Ther. 2019 Dec 11;12:10851-10861. doi: 10.2147/OTT.S220072. eCollection 2019.
4
HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.HOXA-AS2通过miR-520c-3p/GPC3轴促进肝癌细胞增殖并诱导上皮-间质转化
Cell Physiol Biochem. 2018;50(6):2124-2138. doi: 10.1159/000495056. Epub 2018 Nov 9.
5
Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.长链非编码RNA HOXA-AS2通过调控miR-520c-3p/S100A4通路促进甲状腺乳头状癌进展。
Cell Physiol Biochem. 2018;50(5):1659-1672. doi: 10.1159/000494786. Epub 2018 Nov 1.
6
Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.长链非编码RNA HOXA-AS2的敲低通过miR-520c-3p/S100A4轴抑制急性髓系白血病的化疗耐药性。
Cell Physiol Biochem. 2018;51(2):886-896. doi: 10.1159/000495387. Epub 2018 Nov 22.
7
LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.长链非编码 RNA HOXA-AS2 通过靶向 miR-509-3p/PBX3 轴促进前列腺癌的进展。
Biosci Rep. 2020 Aug 28;40(8). doi: 10.1042/BSR20193287.
8
Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer.长链非编码RNA HOXA-AS2通过靶向miR-145-3p在人类非小细胞肺癌中发挥癌基因作用。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1243-1249. doi: 10.26355/eurrev_202002_20177.
9
Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge.长链非编码RNA HOXA-AS2通过充当miR-520c-3p的海绵促进乳腺癌的增殖和侵袭。
Oncotarget. 2017 Jul 11;8(28):46090-46103. doi: 10.18632/oncotarget.17552.
10
LncRNA HOXA-AS2 Promotes Tumor Progression by Suppressing miR-567 Expression in Oral Squamous Cell Carcinoma.长链非编码RNA HOXA-AS2通过抑制miR-567表达促进口腔鳞状细胞癌的肿瘤进展。
Cancer Manag Res. 2021 Jul 8;13:5443-5455. doi: 10.2147/CMAR.S305946. eCollection 2021.
本文引用的文献
1
HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3.HOXA-AS2 通过抑制 miR-2116-3p 从而上调 SERPINA3 来增强 GBM 细胞的恶性程度。
BMC Cancer. 2022 Apr 6;22(1):366. doi: 10.1186/s12885-022-09462-y.
Zotero 插件